NCT03594565View on ClinicalTrials.gov

The Use of Topical Nasal Steroids for Skin Reactions to Continuous Glucose Monitoring System, Among Children and Youth With Type 1 Diabetes Mellitus: Case Series

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

June 30, 2017

Study Completion Date

June 30, 2018

Conditions
T1DMHypersensitivity
Interventions
DRUG

Fluticasone Propionate

Local Fluticasone Propionate use prior to continuous glucose monitoring system insertion

All Listed Sponsors
lead

Assaf-Harofeh Medical Center

OTHER_GOV

NCT03594565 - The Use of Topical Nasal Steroids for Skin Reactions to Continuous Glucose Monitoring System, Among Children and Youth With Type 1 Diabetes Mellitus: Case Series | Biotech Hunter | Biotech Hunter